Technische Universität München

The Entrepreneurial University

 
Beta-2 agonist medications may produce hyperglycemia. Activation of β2-adrenoceptors leads to hepatic glycogenolysis and pancreatic release of glucagon, which increases plasma glucose concentrations.
drucken 

www.doping-prevention.com